Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT03112824
,,22:35:chronic_disease,
BMI of 27 kg/m2 with comorbidities or 30 kg/m2 and above
3
[ "BMI", "of", "27", "kg/m2", "with", "comorbidities", "or", "30", "kg/m2", "and", "above" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT02047474
21:39:treatment
No other concurrent anticancer therapy
3
[ "No", "other", "concurrent", "anticancer", "therapy" ]
[ 0, 0, 0, 1, 1 ]
NCT02501954
1:19:treatment
Surgical Stage IVA includes patients with bladder or bowel mucosal involvement, but no spread outside the pelvis
3
[ "Surgical", "Stage", "IVA", "includes", "patients", "with", "bladder", "or", "bowel", "mucosal", "involvement", ",", "but", "no", "spread", "outside", "the", "pelvis" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02076906
1:15:cancer,25:49:cancer,53:63:cancer
Target lesions that are pulmonary primary tumors or metastases
3
[ "Target", "lesions", "that", "are", "pulmonary", "primary", "tumors", "or", "metastases" ]
[ 3, 3, 0, 0, 3, 3, 3, 0, 3 ]
NCT02865135
24:34:cancer,38:58:treatment,66:72:chronic_disease,96:108:cancer,129:147:cancer
based on expression of HPV type16 in immunohistochemistry and/or HPV 16 DNA analysis by ISH of tumor tissue from the primary or metastatic lesions
3
[ "based", "on", "expression", "of", "HPV", "type16", "in", "immunohistochemistry", "and/or", "HPV", "16", "DNA", "analysis", "by", "ISH", "of", "tumor", "tissue", "from", "the", "primary", "or", "metastatic", "lesions" ]
[ 0, 0, 0, 0, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 3, 3 ]
NCT02942095
1:14:treatment,
Major surgery within 14 days before enrollment
3
[ "Major", "surgery", "within", "14", "days", "before", "enrollment" ]
[ 1, 1, 0, 0, 0, 0, 0 ]
NCT03007030
10:32:cancer,
no prior hematologic malignancy within 3 years
3
[ "no", "prior", "hematologic", "malignancy", "within", "3", "years" ]
[ 0, 0, 3, 3, 0, 0, 0 ]
NCT02508038
,29:39:cancer,41:52:chronic_disease,56:67:cancer
Patients with more than one malignancy (hematologic or solid tumor)
3
[ "Patients", "with", "more", "than", "one", "malignancy", "(", "hematologic", "or", "solid", "tumor", ")" ]
[ 0, 0, 0, 0, 0, 3, 0, 2, 0, 3, 3, 0 ]
NCT01730794
1:20:chronic_disease
Sickle cell disease
3
[ "Sickle", "cell", "disease" ]
[ 2, 2, 2 ]
NCT02431897
5:9:treatment,13:33:treatment,35:39:treatment,50:60:treatment
Any oral or transdermal estrogen, SERM, or other medication impacting vaginal milieu
3
[ "Any", "oral", "or", "transdermal", "estrogen", ",", "SERM", ",", "or", "other", "medication", "impacting", "vaginal", "milieu" ]
[ 0, 1, 0, 1, 1, 0, 1, 0, 0, 0, 1, 0, 0, 0 ]
NCT02189798
1:9:chronic_disease,44:69:chronic_disease,84:117:chronic_disease
Deafness due to central auditory lesion or cochlear nerve deficiency, diagnosis of auditory neuropathy/dys-synchrony in either the ear to be implanted or the contralateral ear
3
[ "Deafness", "due", "to", "central", "auditory", "lesion", "or", "cochlear", "nerve", "deficiency", ",", "diagnosis", "of", "auditory", "neuropathy/dys-synchrony", "in", "either", "the", "ear", "to", "be", "implanted", "or", "the", "contralateral", "ear" ]
[ 2, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02459119
1:26:chronic_disease,,,,
Uncontrolled hypertension (systolic pressure >140 mm Hg or diastolic pressure >90 mm Hg on repeated measurement) despite optimal medical management
3
[ "Uncontrolled", "hypertension", "(", "systolic", "pressure", ">", "140", "mm", "Hg", "or", "diastolic", "pressure", ">", "90", "mm", "Hg", "on", "repeated", "measurement", ")", "despite", "optimal", "medical", "management" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02152254
21:45:treatment,54:72:treatment,91:96:cancer,165:171:treatment
patients who had no prior anticancer therapy and had surgical resection within a year and tumor tissue is immediately available, that tumor will be analyzed and no biopsy will be needed
3
[ "patients", "who", "had", "no", "prior", "anticancer", "therapy", "and", "had", "surgical", "resection", "within", "a", "year", "and", "tumor", "tissue", "is", "immediately", "available", ",", "that", "tumor", "will", "be", "analyzed", "and", "no", "biopsy", "will", "be", "needed" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02730481
1:25:chronic_disease,27:45:chronic_disease,47:72:chronic_disease,97:115:chronic_disease
unstable angina pectoris, cardiac arrhythmia, chronic pulmonary disease requiring oxygen, known bleeding disorders, or any concomitant illness or social situation that would limit compliance with study requirements
3
[ "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia", ",", "chronic", "pulmonary", "disease", "requiring", "oxygen", ",", "known", "bleeding", "disorders", ",", "or", "any", "concomitant", "illness", "or", "social", "situation", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 2, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03067571
26:36:cancer,,90:136:cancer,141:172:cancer
has a history of another malignancy within 5 years before cycle 1, day 1 (exceptions are squamous and basal cell carcinomas of the skin and carcinoma in situ of the cervix, or malignancy that in the opinion of the investigator, with concurrence with the IND office and supporter's medical monitor, is considered cured with minimal risk of recurrence)
3
[ "has", "a", "history", "of", "another", "malignancy", "within", "5", "years", "before", "cycle", "1", ",", "day", "1", "(", "exceptions", "are", "squamous", "and", "basal", "cell", "carcinomas", "of", "the", "skin", "and", "carcinoma", "in", "situ", "of", "the", "cervix", ",", "or", "malignancy", "that", "in", "the", "opinion", "of", "the", "investigator", ",", "with", "concurrence", "with", "the", "IND", "office", "and", "supporter", "'s", "medical", "monitor", ",", "is", "considered", "cured", "with", "minimal", "risk", "of", "recurrence", ")" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 3, 3, 3, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02905370
1:7:chronic_disease
Hernia
3
[ "Hernia" ]
[ 2 ]
NCT02268448
17:47:treatment,
Subjects taking hormone-containing medications must be on a stable dose for 6 months prior to study start to avoid any confounding influence on sensory and pain perception
3
[ "Subjects", "taking", "hormone-containing", "medications", "must", "be", "on", "a", "stable", "dose", "for", "6", "months", "prior", "to", "study", "start", "to", "avoid", "any", "confounding", "influence", "on", "sensory", "and", "pain", "perception" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01473784
90:110:treatment
Patients must have adequate transoral exposure of the oral cavity and laryngopharynx for TORS instrumentation
3
[ "Patients", "must", "have", "adequate", "transoral", "exposure", "of", "the", "oral", "cavity", "and", "laryngopharynx", "for", "TORS", "instrumentation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02004275
4:17:treatment,
No major surgery within 28 days prior to registration
3
[ "No", "major", "surgery", "within", "28", "days", "prior", "to", "registration" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02588326
13:20:chronic_disease,22:34:chronic_disease,36:52:chronic_disease,54:61:chronic_disease,63:68:chronic_disease,70:83:chronic_disease,85:97:chronic_disease,102:121:chronic_disease,152:173:treatment,175:185:treatment
Significant cardiac, dermatologic, gastrointestinal, hepatic, renal, hematological, neurological and psychiatric disease (determined by physical exam, CBC with differential, urinalysis, basic metabolic panel and medical history)
3
[ "Significant", "cardiac", ",", "dermatologic", ",", "gastrointestinal", ",", "hepatic", ",", "renal", ",", "hematological", ",", "neurological", "and", "psychiatric", "disease", "(", "determined", "by", "physical", "exam", ",", "CBC", "with", "differential", ",", "urinalysis", ",", "basic", "metabolic", "panel", "and", "medical", "history", ")" ]
[ 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02431806
43:59:chronic_disease
Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Disorder (MDD) , confirmed by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children--Present and Lifetime (K-SADS-PL)
3
[ "Meet", "Diagnostic", "and", "Statistical", "Manual", "of", "Mental", "Disorders", ",", "Fourth", "Edition", ",", "Text", "Revision", "(", "DSM-IV-TR", ")", "criteria", "for", "Major", "Depressive", "Disorder", "(", "MDD", ")", ",", "confirmed", "by", "Kiddie", "Schedule", "for", "Affective", "Disorders", "and", "Schizophrenia", "for", "School-Age", "Children", "--", "Present", "and", "Lifetime", "(", "K-SADS-PL", ")" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01434316
,,38:55:treatment,
Hemoglobin (Hgb) > 10.0 g/dL with no blood transfusion in the past 28 day
3
[ "Hemoglobin", "(", "Hgb", ")", ">", "10.0", "g/dL", "with", "no", "blood", "transfusion", "in", "the", "past", "28", "day" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02419495
28:43:treatment
Able to swallow and retain oral medication
3
[ "Able", "to", "swallow", "and", "retain", "oral", "medication" ]
[ 0, 0, 0, 0, 0, 1, 1 ]
NCT02833207
,,71:98:chronic_disease
Females: Self-reported pregnancy and/or breastfeeding, diagnosed with polycystic ovarian syndrome, or without regular menses
3
[ "Females", ":", "Self-reported", "pregnancy", "and/or", "breastfeeding", ",", "diagnosed", "with", "polycystic", "ovarian", "syndrome", ",", "or", "without", "regular", "menses" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT03078504
1:18:treatment
Arterial catheter present for continuous blood pressure monitoring
3
[ "Arterial", "catheter", "present", "for", "continuous", "blood", "pressure", "monitoring" ]
[ 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02114229
,52:65:treatment
At least 14 days must have elapsed after receiving pegfilgrastim
3
[ "At", "least", "14", "days", "must", "have", "elapsed", "after", "receiving", "pegfilgrastim" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02519348
1:8:chronic_disease,19:49:treatment,55:67:treatment,
Ascites requiring non-pharmacologic intervention (eg, paracentesis) to maintain symptomatic control, within 6 months prior to the first scheduled dose
3
[ "Ascites", "requiring", "non-pharmacologic", "intervention", "(", "eg", ",", "paracentesis", ")", "to", "maintain", "symptomatic", "control", ",", "within", "6", "months", "prior", "to", "the", "first", "scheduled", "dose" ]
[ 2, 0, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02356848
8:21:treatment,
Recent major surgery (< 3 months)
3
[ "Recent", "major", "surgery", "(", "<", "3", "months", ")" ]
[ 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT01187368
19:36:treatment
Patients refusing blood transfusion
3
[ "Patients", "refusing", "blood", "transfusion" ]
[ 0, 0, 1, 1 ]
NCT00492778
35:54:chronic_disease
Patients must have no evidence of extrapelvic disease
3
[ "Patients", "must", "have", "no", "evidence", "of", "extrapelvic", "disease" ]
[ 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02905370
1:9:chronic_disease
Diabetes
3
[ "Diabetes" ]
[ 2 ]
NCT02520713
1:35:cancer
Inflammatory myofibroblastic tumor without ALK fusion
3
[ "Inflammatory", "myofibroblastic", "tumor", "without", "ALK", "fusion" ]
[ 3, 3, 3, 0, 0, 0 ]
NCT01989585
,,,,286:315:treatment,317:349:treatment,354:362:treatment
Patients must have measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded for non-nodal lesions and short axis for nodal lesions) as >= 20 mm with conventional techniques or as >= 10 mm with spiral computed tomography (CT) scan, magnetic resonance imaging (MRI), or calipers by clinical exam
3
[ "Patients", "must", "have", "measurable", "disease", ",", "defined", "as", "at", "least", "one", "lesion", "that", "can", "be", "accurately", "measured", "in", "at", "least", "one", "dimension", "(", "longest", "diameter", "to", "be", "recorded", "for", "non-nodal", "lesions", "and", "short", "axis", "for", "nodal", "lesions", ")", "as", ">", "=", "20", "mm", "with", "conventional", "techniques", "or", "as", ">", "=", "10", "mm", "with", "spiral", "computed", "tomography", "(", "CT", ")", "scan", ",", "magnetic", "resonance", "imaging", "(", "MRI", ")", ",", "or", "calipers", "by", "clinical", "exam" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02354547
23:45:chronic_disease
No evidence of active graft vs. host disease
3
[ "No", "evidence", "of", "active", "graft", "vs.", "host", "disease" ]
[ 0, 0, 0, 0, 2, 2, 2, 2 ]
NCT02184520
1:15:chronic_disease,,,,
Morbid obesity defined as a body mass index > 40, or a weight more than 100 lbs over ideal body weight
3
[ "Morbid", "obesity", "defined", "as", "a", "body", "mass", "index", ">", "40", ",", "or", "a", "weight", "more", "than", "100", "lbs", "over", "ideal", "body", "weight" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02403193
112:129:treatment
EGFR mutation with exon 19 deletion or L858R mutation (Exon 21) or ALK rearrangement positive must have failed prior TKI therapy
3
[ "EGFR", "mutation", "with", "exon", "19", "deletion", "or", "L858R", "mutation", "(", "Exon", "21", ")", "or", "ALK", "rearrangement", "positive", "must", "have", "failed", "prior", "TKI", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02374333
7:15:cancer
CD19+ leukemia
3
[ "CD19+", "leukemia" ]
[ 0, 3 ]
NCT02332668
1:35:chronic_disease
Human immunodeficiency virus (HIV)
3
[ "Human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 2, 2, 2, 2, 0, 0 ]
NCT02162420
14:28:chronic_disease
Diagnosis of Fanconi anemia based on DEB
3
[ "Diagnosis", "of", "Fanconi", "anemia", "based", "on", "DEB" ]
[ 0, 0, 2, 2, 0, 0, 0 ]
NCT00147056
1:23:treatment,28:39:treatment,66:76:chronic_disease,85:131:treatment,133:140:treatment
Anti-coagulant therapy, on medications known to increase risk of hemorrhage, (e.g.: non-steroidal anti-inflammatory drugs (NSAIDs), statins
3
[ "Anti-coagulant", "therapy", ",", "on", "medications", "known", "to", "increase", "risk", "of", "hemorrhage", ",", "(", "e.g", ".", ":", "non-steroidal", "anti-inflammatory", "drugs", "(", "NSAIDs", ")", ",", "statins" ]
[ 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 1 ]
NCT02807883
5:21:cancer,,,,90:93:treatment,213:223:treatment,
any residual disease defined by positive flow >0.01%, detection of BCR-ABL transcript by PCR with a sensitivity of 1/10,000, or detection of the t(9;22) translocation in any metaphases by cytogenetics at time of transplant, or presence of the MLL gene
3
[ "any", "residual", "disease", "defined", "by", "positive", "flow", ">", "0.01", "%", ",", "detection", "of", "BCR-ABL", "transcript", "by", "PCR", "with", "a", "sensitivity", "of", "1/10,000", ",", "or", "detection", "of", "the", "t", "(", "9", ";", "22", ")", "translocation", "in", "any", "metaphases", "by", "cytogenetics", "at", "time", "of", "transplant", ",", "or", "presence", "of", "the", "MLL", "gene" ]
[ 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02830074
23:41:chronic_disease
with no evidence of a neurologic deficit based on ASIA classification
3
[ "with", "no", "evidence", "of", "a", "neurologic", "deficit", "based", "on", "ASIA", "classification" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT02155699
38:70:allergy_name,81:93:allergy_name,95:107:allergy_name,111:128:allergy_name,130:140:allergy_name,142:159:allergy_name,169:194:allergy_name
people who have contraindications to magnetic resonance (MR) scanning including intracranial, intraorbital or intraspinal metal, pacemakers, cochlear implants or other non-MR-compatible devices
3
[ "people", "who", "have", "contraindications", "to", "magnetic", "resonance", "(", "MR", ")", "scanning", "including", "intracranial", ",", "intraorbital", "or", "intraspinal", "metal", ",", "pacemakers", ",", "cochlear", "implants", "or", "other", "non-MR-compatible", "devices" ]
[ 0, 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 4, 0, 4, 0, 4, 4, 0, 4, 0, 4, 4, 0, 0, 4, 4 ]
NCT02578901
,,,112:122:treatment,
Subjects who are pregnant or nursing or unwilling to use contraception during and for 30 days after taking the study drug (both males and females)
3
[ "Subjects", "who", "are", "pregnant", "or", "nursing", "or", "unwilling", "to", "use", "contraception", "during", "and", "for", "30", "days", "after", "taking", "the", "study", "drug", "(", "both", "males", "and", "females", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01940757
32:65:chronic_disease
Positive confirmatory test for hepatitis C virus (HCV) infection
3
[ "Positive", "confirmatory", "test", "for", "hepatitis", "C", "virus", "(", "HCV", ")", "infection" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02186418
29:56:treatment,68:79:treatment,91:98:chronic_disease
Patients who were placed on chronic transfusion therapy instead of hydroxyurea for severe disease
3
[ "Patients", "who", "were", "placed", "on", "chronic", "transfusion", "therapy", "instead", "of", "hydroxyurea", "for", "severe", "disease" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 0, 0, 2 ]
NCT02962128
8:15:treatment,17:23:treatment,27:35:treatment,45:71:treatment
use of statins, niacin or fibrates or other lipid lowering medications
3
[ "use", "of", "statins", ",", "niacin", "or", "fibrates", "or", "other", "lipid", "lowering", "medications" ]
[ 0, 0, 1, 0, 1, 0, 1, 0, 0, 1, 1, 1 ]
NCT00967577
8:23:chronic_disease,,,
Active angina pectoris or NY Heart Association Class III-IV
3
[ "Active", "angina", "pectoris", "or", "NY", "Heart", "Association", "Class", "III-IV" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT03088072
28:39:treatment,47:53:chronic_disease,55:72:chronic_disease,74:82:chronic_disease,84:105:chronic_disease
Procedural complication of LAA closure (e.g., stroke, systemic embolism, bleeding, vascular complication
3
[ "Procedural", "complication", "of", "LAA", "closure", "(", "e.g.", ",", "stroke", ",", "systemic", "embolism", ",", "bleeding", ",", "vascular", "complication" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 2, 0, 2, 2, 0, 2, 0, 2, 2 ]
NCT02465060
11:19:treatment,31:57:treatment,66:78:treatment,90:99:treatment,100:113:treatment,115:126:treatment
suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used
3
[ "suggested", "regimens", "to", "replace", "protease", "inhibitor", "therapy", "include", "dolutegravir", "given", "with", "tenofovir/emtricitabine", ";", "raltegravir", "given", "with", "tenofovir", "and", "emtricitabine", ";", "once", "daily", "combinations", "that", "use", "pharmacologic", "boosters", "may", "not", "be", "used" ]
[ 0, 1, 0, 0, 1, 1, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02317523
8:31:treatment
Taking Coumarin anticoagulants
3
[ "Taking", "Coumarin", "anticoagulants" ]
[ 0, 1, 1 ]
NCT02819843
20:34:treatment,36:52:treatment,54:66:treatment,68:91:treatment,93:106:treatment,108:120:treatment,124:131:treatment
Receipt of another cancer therapy (targeted therapy, chemotherapy, investigational therapy, immunotherapy, radiotherapy or surgery) which is yielding an overall response (by response criteria in this study)
3
[ "Receipt", "of", "another", "cancer", "therapy", "(", "targeted", "therapy", ",", "chemotherapy", ",", "investigational", "therapy", ",", "immunotherapy", ",", "radiotherapy", "or", "surgery", ")", "which", "is", "yielding", "an", "overall", "response", "(", "by", "response", "criteria", "in", "this", "study", ")" ]
[ 0, 0, 0, 1, 1, 0, 1, 1, 0, 1, 0, 1, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02338232
1:28:chronic_disease
Myeloproliferative disorder
3
[ "Myeloproliferative", "disorder" ]
[ 2, 2 ]
NCT01919619
1:18:treatment,
antifungal agents within 14 days of first dose
3
[ "antifungal", "agents", "within", "14", "days", "of", "first", "dose" ]
[ 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01269034
1:9:cancer
leukemia
3
[ "leukemia" ]
[ 3 ]
NCT02074631
12:34:chronic_disease,38:56:chronic_disease,64:77:chronic_disease,81:83:chronic_disease,88:115:chronic_disease
Hereditary metabolic bone disease or skeletal dysplasia (e.g., osteopetrosis or OI) or primary hyperparathyroidism
3
[ "Hereditary", "metabolic", "bone", "disease", "or", "skeletal", "dysplasia", "(", "e.g.", ",", "osteopetrosis", "or", "OI", ")", "or", "primary", "hyperparathyroidism" ]
[ 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 2, 0, 2, 0, 0, 2, 2 ]
NCT02921022
,,,122:130:treatment
Prothrombin time (PT)/international normalized ratio (INR) within normal limits (±15%) or within therapeutic range if on warfarin
3
[ "Prothrombin", "time", "(", "PT", ")", "/international", "normalized", "ratio", "(", "INR", ")", "within", "normal", "limits", "(", "±15", "%", ")", "or", "within", "therapeutic", "range", "if", "on", "warfarin" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT00044304
,30:48:treatment
dysplastic megakaryocytes on bone marrow biopsy
3
[ "dysplastic", "megakaryocytes", "on", "bone", "marrow", "biopsy" ]
[ 0, 0, 0, 1, 1, 1 ]
NCT02290028
21:34:allergy_name
Contraindication to CRT-D therapy
3
[ "Contraindication", "to", "CRT-D", "therapy" ]
[ 0, 0, 4, 4 ]
NCT01954316
10:23:treatment,
Have had major surgery within 21 days of starting therapy
3
[ "Have", "had", "major", "surgery", "within", "21", "days", "of", "starting", "therapy" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02195232
25:41:cancer,71:85:treatment,161:183:chronic_disease
Participants with known brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events
3
[ "Participants", "with", "known", "brain", "metastases", "should", "be", "excluded", "from", "this", "clinical", "trial", "because", "of", "their", "poor", "prognosis", "and", "because", "they", "often", "develop", "progressive", "neurologic", "dysfunction", "that", "would", "confound", "the", "evaluation", "of", "neurologic", "and", "other", "adverse", "events" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03005951
21:38:treatment
Previous history of bariatric surgery
3
[ "Previous", "history", "of", "bariatric", "surgery" ]
[ 0, 0, 0, 1, 1 ]
NCT02152995
3:14:treatment,20:37:cancer,90:111:treatment,
A radioiodine-avid metastatic lesion which remained stable in size or progressed despite radioiodine treatment 6 months or more prior to entry in the study; there are no size limitations for the index lesion used to satisfy this entry criterion
3
[ "A", "radioiodine-avid", "metastatic", "lesion", "which", "remained", "stable", "in", "size", "or", "progressed", "despite", "radioiodine", "treatment", "6", "months", "or", "more", "prior", "to", "entry", "in", "the", "study", ";", "there", "are", "no", "size", "limitations", "for", "the", "index", "lesion", "used", "to", "satisfy", "this", "entry", "criterion" ]
[ 0, 1, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02192398
5:16:treatment,106:116:treatment,196:223:treatment,235:249:treatment,254:267:treatment,268:281:treatment
Any medications taken by a subject at the enrollment will be reviewed regarding their compatibility with guanfacine as well as possible confounding side effects. Subjects will be allowed to take non-opioid pain medications except for gabapentinoids and amitriptyline/nortriptyline as far as such medications do not have incompatibility with guanfacine
3
[ "Any", "medications", "taken", "by", "a", "subject", "at", "the", "enrollment", "will", "be", "reviewed", "regarding", "their", "compatibility", "with", "guanfacine", "as", "well", "as", "possible", "confounding", "side", "effects", ".", "Subjects", "will", "be", "allowed", "to", "take", "non-opioid", "pain", "medications", "except", "for", "gabapentinoids", "and", "amitriptyline/nortriptyline", "as", "far", "as", "such", "medications", "do", "not", "have", "incompatibility", "with", "guanfacine" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01589263
1:22:chronic_disease
Uncontrolled diabetes
3
[ "Uncontrolled", "diabetes" ]
[ 2, 2 ]
NCT02061293
14:36:chronic_disease,38:51:chronic_disease,53:77:chronic_disease,79:95:chronic_disease,105:129:chronic_disease,139:169:chronic_disease
Exclusionary psychiatric conditions (schizophrenia, schizoaffective disorder, bipolar disorder, current major depressive episode, current post-traumatic stress disorder, current suicidality or history of medically serious suicide attempt)
3
[ "Exclusionary", "psychiatric", "conditions", "(", "schizophrenia", ",", "schizoaffective", "disorder", ",", "bipolar", "disorder", ",", "current", "major", "depressive", "episode", ",", "current", "post-traumatic", "stress", "disorder", ",", "current", "suicidality", "or", "history", "of", "medically", "serious", "suicide", "attempt", ")" ]
[ 0, 2, 2, 0, 2, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02227199
,,126:136:allergy_name,138:149:allergy_name,154:163:allergy_name
Patients with known allergy, intolerance, or resistance (i.e., remission duration less than 6 months or lack of response) to ifosfamide, carboplatin, or etoposide
3
[ "Patients", "with", "known", "allergy", ",", "intolerance", ",", "or", "resistance", "(", "i.e.", ",", "remission", "duration", "less", "than", "6", "months", "or", "lack", "of", "response", ")", "to", "ifosfamide", ",", "carboplatin", ",", "or", "etoposide" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 4, 0, 0, 4 ]
NCT02335242
1:11:treatment
Cimetidine
3
[ "Cimetidine" ]
[ 1 ]
NCT02494869
25:45:cancer
Cytologically confirmed atypical hyperplasia
3
[ "Cytologically", "confirmed", "atypical", "hyperplasia" ]
[ 0, 0, 3, 3 ]
NCT03137758
20:47:treatment
concomitant use of therapeutic anticoagulation
3
[ "concomitant", "use", "of", "therapeutic", "anticoagulation" ]
[ 0, 0, 0, 1, 1 ]
NCT02513485
44:53:chronic_disease,55:69:chronic_disease,71:80:chronic_disease,82:95:chronic_disease,97:102:chronic_disease,107:127:chronic_disease
Evidence of untreated or poorly controlled endocrine, cardiovascular, pulmonary, hematological, renal, or neurological disease
3
[ "Evidence", "of", "untreated", "or", "poorly", "controlled", "endocrine", ",", "cardiovascular", ",", "pulmonary", ",", "hematological", ",", "renal", ",", "or", "neurological", "disease" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 0, 2, 2 ]
NCT02253316
1:22:chronic_disease,
myocardial infarction within the previous six months
3
[ "myocardial", "infarction", "within", "the", "previous", "six", "months" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02134392
1:28:cancer
gastrointestinal malignancy
3
[ "gastrointestinal", "malignancy" ]
[ 3, 3 ]
NCT02859142
18:34:chronic_disease
history of major suicide attempts
3
[ "history", "of", "major", "suicide", "attempts" ]
[ 0, 0, 0, 2, 2 ]
NCT02152956
1:9:chronic_disease
vitiligo
3
[ "vitiligo" ]
[ 2 ]
NCT01681264
53:69:allergy_name,76:83:allergy_name,85:95:allergy_name,97:104:allergy_name,106:134:allergy_name
Allergic to or has had a severe adverse reaction to study medication (i.e. opioids, guanfacine, lactose, vitamin B2 a.k.a. riboflavin)
3
[ "Allergic", "to", "or", "has", "had", "a", "severe", "adverse", "reaction", "to", "study", "medication", "(", "i.e", ".", "opioids", ",", "guanfacine", ",", "lactose", ",", "vitamin", "B2", "a.k.a", ".", "riboflavin", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 4, 0, 4, 0, 4, 0, 4, 4, 4, 4, 0, 0 ]
NCT02775162
64:85:treatment
registered as an active recipient on the UNOS waiting list for liver transplantation
3
[ "registered", "as", "an", "active", "recipient", "on", "the", "UNOS", "waiting", "list", "for", "liver", "transplantation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT00959140
13:34:chronic_disease
evidence of progressive infection by imaging studies
3
[ "evidence", "of", "progressive", "infection", "by", "imaging", "studies" ]
[ 0, 0, 2, 2, 0, 0, 0 ]
NCT01312857
20:46:cancer
Adequately treated cervical carcinoma in situ without evidence of disease
3
[ "Adequately", "treated", "cervical", "carcinoma", "in", "situ", "without", "evidence", "of", "disease" ]
[ 0, 0, 3, 3, 3, 3, 0, 0, 0, 0 ]
NCT00809991
12:38:chronic_disease
History of inflammatory bowel disease
3
[ "History", "of", "inflammatory", "bowel", "disease" ]
[ 0, 0, 2, 2, 2 ]
NCT03040726
22:39:chronic_disease
Clinical evidence of bowel obstruction at the time of study enrollment
3
[ "Clinical", "evidence", "of", "bowel", "obstruction", "at", "the", "time", "of", "study", "enrollment" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02296684
1:20:treatment,28:37:treatment,39:46:treatment,51:97:treatment,102:109:chronic_disease,113:136:chronic_disease
Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.)
3
[ "Replacement", "therapy", "(", "e.g.", ",", "thyroxine", ",", "insulin", ",", "or", "physiologic", "corticosteroid", "replacement", "therapy", "for", "adrenal", "or", "pituitary", "insufficiency", ",", "etc", ".", ")" ]
[ 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 2, 2, 0, 0, 0, 0 ]
NCT03168776
29:45:treatment
on the waiting list for any organ transplant
3
[ "on", "the", "waiting", "list", "for", "any", "organ", "transplant" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02943408
32:48:chronic_disease
other specified or unspecified anxiety disorder (300.09, 300.00)
3
[ "other", "specified", "or", "unspecified", "anxiety", "disorder", "(", "300.09", ",", "300.00", ")" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT01446094
18:35:treatment
Individuals with cochlear implants
3
[ "Individuals", "with", "cochlear", "implants" ]
[ 0, 0, 1, 1 ]
NCT03179397
1:20:chronic_disease
Optic nerve atrophy
3
[ "Optic", "nerve", "atrophy" ]
[ 2, 2, 2 ]
NCT03104699
1:22:chronic_disease,
myocardial infarction (<6 months before enrollment)
3
[ "myocardial", "infarction", "(", "<", "6", "months", "before", "enrollment", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT03158519
1:22:chronic_disease,
myocardial infarction in the prior 12 months
3
[ "myocardial", "infarction", "in", "the", "prior", "12", "months" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT03077243
45:53:chronic_disease,61:80:chronic_disease,97:119:treatment
Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects (Note, however, coagulation parameters are not required for entry into this protocol)
3
[ "Hepatic", "insufficiency", "resulting", "in", "clinical", "jaundice", "and/or", "coagulation", "defects", "(", "Note", ",", "however", ",", "coagulation", "parameters", "are", "not", "required", "for", "entry", "into", "this", "protocol", ")" ]
[ 0, 0, 0, 0, 0, 2, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00716066
15:24:chronic_disease,26:33:chronic_disease,35:42:chronic_disease,46:62:chronic_disease,105:126:treatment
Patients with pulmonary, cardiac, hepatic or renal impairment that would limit their ability to receive cytoreductive therapy and compromise their survival
3
[ "Patients", "with", "pulmonary", ",", "cardiac", ",", "hepatic", "or", "renal", "impairment", "that", "would", "limit", "their", "ability", "to", "receive", "cytoreductive", "therapy", "and", "compromise", "their", "survival" ]
[ 0, 0, 2, 0, 2, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02316574
28:48:chronic_disease,60:80:chronic_disease,87:112:chronic_disease,114:142:chronic_disease,219:265:treatment
A diagnosis of any current psychiatric disorder other than Alcohol Use Disorder (e.g. Major Depressive Disorder, Generalized Anxiety Disorder) that in the investigator's judgment might require intervention with either pharmacological or non-pharmacological therapy over the course of the study
3
[ "A", "diagnosis", "of", "any", "current", "psychiatric", "disorder", "other", "than", "Alcohol", "Use", "Disorder", "(", "e.g", ".", "Major", "Depressive", "Disorder", ",", "Generalized", "Anxiety", "Disorder", ")", "that", "in", "the", "investigator", "'s", "judgment", "might", "require", "intervention", "with", "either", "pharmacological", "or", "non-pharmacological", "therapy", "over", "the", "course", "of", "the", "study" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01811368
1:13:treatment,
radiotherapy must have been completed at least 4 weeks prior to entry into the study
3
[ "radiotherapy", "must", "have", "been", "completed", "at", "least", "4", "weeks", "prior", "to", "entry", "into", "the", "study" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03093909
4:16:treatment,
No radiotherapy within 2 weeks
3
[ "No", "radiotherapy", "within", "2", "weeks" ]
[ 0, 1, 0, 0, 0 ]
NCT01953263
20:81:treatment
Patients requiring concomitant use of or treatment with immunosuppressive agents
3
[ "Patients", "requiring", "concomitant", "use", "of", "or", "treatment", "with", "immunosuppressive", "agents" ]
[ 0, 0, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT03008408
14:21:treatment,23:58:treatment,62:74:treatment
Therapy with heparin, low molecular weight heparin (LMWH) or fondaparinux
3
[ "Therapy", "with", "heparin", ",", "low", "molecular", "weight", "heparin", "(", "LMWH", ")", "or", "fondaparinux" ]
[ 0, 0, 1, 0, 1, 1, 1, 1, 1, 0, 0, 0, 1 ]
NCT02572323
21:40:chronic_disease,58:71:treatment,84:93:treatment
Active or relapsing autoimmune disorder that may require immunotherapy during this treatment trial
3
[ "Active", "or", "relapsing", "autoimmune", "disorder", "that", "may", "require", "immunotherapy", "during", "this", "treatment", "trial" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 1, 0, 0, 1, 0 ]
NCT03054519
1:22:chronic_disease,,,
Chronic liver disease defined as two or more hepatic function tests >2.0 times the upper limit of normal
3
[ "Chronic", "liver", "disease", "defined", "as", "two", "or", "more", "hepatic", "function", "tests", ">", "2.0", "times", "the", "upper", "limit", "of", "normal" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02354547
1:24:treatment
Concomitant medications
3
[ "Concomitant", "medications" ]
[ 1, 1 ]
NCT02807272
1:17:chronic_disease,23:34:chronic_disease,38:49:chronic_disease
active infection with hepatitis B or hepatitis C
3
[ "active", "infection", "with", "hepatitis", "B", "or", "hepatitis", "C" ]
[ 2, 2, 0, 2, 2, 0, 0, 0 ]
NCT02490631
1:17:treatment
chronic steroids
3
[ "chronic", "steroids" ]
[ 1, 1 ]